Page last updated: 2024-11-06

lysergic acid diethylamide and Agoraphobia

lysergic acid diethylamide has been researched along with Agoraphobia in 2 studies

Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.

Agoraphobia: Obsessive, persistent, intense fear of open places.

Research Excerpts

ExcerptRelevanceReference
"Patients ultimately presented for treatment of agoraphobia."1.27Depersonalization and agoraphobia associated with marijuana use. ( Moran, C, 1986)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Norman, TR1
Judd, FK1
Staikos, V1
Burrows, GD1
McIntyre, IM1
Moran, C1

Other Studies

2 other studies available for lysergic acid diethylamide and Agoraphobia

ArticleYear
High-affinity platelet [3H]LSD binding is decreased in panic disorder.
    Journal of affective disorders, 1990, Volume: 19, Issue:2

    Topics: Adult; Agoraphobia; Blood Platelets; Fear; Female; Humans; Lysergic Acid Diethylamide; Male; Middle

1990
Depersonalization and agoraphobia associated with marijuana use.
    The British journal of medical psychology, 1986, Volume: 59 ( Pt 2)

    Topics: Adult; Agoraphobia; Behavior Therapy; Cannabis; Depersonalization; Female; Humans; Lysergic Acid Die

1986